The sodium salt of diethyl 1H-pyrazole-3,5-dicarboxylate as an efficient amphiphilic receptor for dopamine and amphetamines. Crystal structure and solution studies

Journal of the American Chemical Society

Volumn 128, Issue 51, 2006, Pages 16458-16459

  Reviriego, Felipe ^a   Rodríguez Franco, Maria Isabel ^a   Navarro, Pilar ^a   García España, Enrique ^b   Liu González, Malva ^b   Verdejo, Begoña ^b   Domènech, Antonio ^b  

^a INSTITUTO DE QUÍMICA MÉDICA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DIETHYL 1H PYRAZOLE 3,5 DICARBOXYLATE SODIUM; DOPAMINE; DOPAMINE RECEPTOR; METHAMPHETAMINE; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BEHAVIOR; BLOOD BRAIN BARRIER; BRAIN FUNCTION; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; COMPLEX FORMATION; CRYSTAL STRUCTURE; DRUG ABUSE; DRUG RECEPTOR BINDING; ELECTROSPRAY MASS SPECTROMETRY; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; HYDROGEN BOND; INFRARED SPECTROSCOPY; NEUROCHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE; STOICHIOMETRY; STRUCTURE ANALYSIS; X RAY DIFFRACTION;

AMPHETAMINES; CARBOXYLIC ACIDS; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DOPAMINE; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PYRAZOLES; SALTS; SOLUTIONS; STEREOISOMERISM; WATER;

EID: 33845947975     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja064657h     Document Type: Article

References (24)

1. Sulzer, D.; Sonders, M. S.; Poulsen, N. W.; Dalli, A. Prog. Neurobiol. 2005, 75, 406-433.
2. Cadet, J. L.; Jayanthi, S.; Deng, X. FASEB J. 2003, 17, 1776-1788 and references cited therein.
3. McCann, U. D.; Ricaurte, G. A. Neurosci. Biobehav. Rev. 2004, 27, 821-826.
4. Kovacic, P. Med. Hypotheses 2005, 65, 90-96.
5. (a) Campayo, L.; Bueno, J. M.; Ochoa, C.; Navarro, P.; Jiménez-Barbero, J.; Pèpe, G.; Samat, A. J. Org. Chem. 1997, 62, 2684-2693.
6. (b) Rodríguez-Franco, M. I.; San Lorenzo, P.; Martínez, A.; Navarro, P. Tetrahedron 1999, 55, 2763-2772.
7. (c) Rübeling, D.; Schrader, T. J. Am. Chem. Soc. 2003, 125, 12086-12087.
8. (a) Lamarque, L.; Navarro, P.; Miranda, C.; Arán, V. J.; Ochoa, C.; Escartí, F.; García-España, E.; Latorre, J.; Luis, S. V.; Miravet, J. F. J. Am. Chem. Soc. 2001. 123, 10560-10570.
9. (b) Herm, M.; Molt, O.; Schrader, T. Chem.-Eur. J. 2002, 8, 1485-1499.
10. (c) Escuder, B.; Rowan, A. E.; Feiters, M. C.; Nolte, R. J. M. Tetrahedron 2004, 60, 291-300.
11. (d) Coskun, A.; Akkaya, E. U. Org. Lett. 2004, 6, 3107-3109.
12. (e) Secor, K. E.; Glass, T. E. Org. Lett. 2004, 6, 3727-3730.
13. (a) Hyun, M. H.; Jin, J. S.; Koo, H. J.; Lee, W. J. Chromatogr. A 1998, 837, 75-82.
14. (b) Jun, M. H.; Han, S. C.; Lipshutz, B. H.; Shin, Y.-J.; Welch, C. J. J. Chromatogr. A 2002, 950, 75-83.
15. (a) Domènech, A.; García-España, E.; Navarro, P.; Reviriego, F. Talanta 2000, 51, 625-636.
16. (b) Reviriego, F.; Navarro, P.; Domènech, A.; García- España, E. J. Chem. Soc., Perkin Trans. 2 2002, 1634-1638.
17. 2 = 0.1300 (all data).
18. (a) Beltrán, A.; Beltrán, D.; Domènech, A.; Cervilla, A.; Ramírez, J. A. Talanta 1983, 30, 124-126.
19. (b) Bianchi, A.; Domènech, A.; García-España, E.; Luis, S. V. Anal. Chem. 1993, 65, 3137-3142.
20. -3 NaCl. The program HYPERQUAD (Gans, P.; Sabatini, A.; Vacca, A. Talanta 1996, 43, 1739-1753) was used to compute the protonation and stability constants.
21. (a) Kansy, M.; Senner, F.; Gubernator, K. J. Med. Chem. 1998, 41, 1007-1010.
22. (b) Di, L.; Kerns, E. H.; Fan, K.; McConnell, O. J.; Carter, G. T. Eur. J. Med. Chem. 2003, 38, 223-232 and references cited therein.
23. (a) Rodríguez-Franco, M. I.; Fernández-Bachiller, M. I.; Pérez, C.; Hernández-Ledesma, B.; Bartolomé, B. J. Med. Chem. 2006, 49, 459-462.
24. (b) Pavón, F. J.; Hernández-Folgado, L.; Bilbao, A.; Cippitelli, A.; Jagerovic, N.; Abellán, G.; Rodríguez-Franco, M. I.; Serrano, A.; Macías, M.; Navarro, M.; Goya, P.; Rodríguez de Fonseca, F. Neuropharmacology 2006, 51, 358-366.